Location History:
- Davis, CA (US) (2003 - 2004)
- San Ramon, CA (US) (2003 - 2004)
- Plainsboro, NJ (US) (2011)
- Wynnewood, PA (US) (2008 - 2017)
- Wynnewood, CA (US) (2017)
Company Filing History:
Years Active: 2003-2017
Title: Partha S Banerjee: Innovator in Bronchodilating Compositions
Introduction
Partha S Banerjee is a notable inventor based in Wynnewood, PA (US). He has made significant contributions to the field of bronchodilating compositions, holding a total of 16 patents. His work focuses on developing innovative methods and compositions for treating bronchoconstrictive disorders.
Latest Patents
Among his latest patents are two key innovations. The first is titled "Bronchodilating beta-agonist compositions and methods." This patent provides compositions intended for administration as a nebulized aerosol, which contain formoterol or a derivative thereof. The methods outlined aim for the treatment, prevention, or amelioration of symptoms associated with bronchoconstrictive disorders. The second patent, "Formoterol/steroid bronchodilating compositions and methods of use thereof," also focuses on nebulized aerosol compositions. This invention combines formoterol with a steroidal anti-inflammatory agent, further enhancing treatment options for bronchoconstrictive disorders.
Career Highlights
Throughout his career, Partha S Banerjee has worked with prominent companies, including Dey, L.P. and JPMorgan Chase Bank, N.A. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.
Collaborations
Partha has collaborated with notable professionals in his field, including Imtiaz A Chaudry and Stephen Pham. These collaborations have likely enriched his research and development efforts.
Conclusion
Partha S Banerjee stands out as an influential inventor in the realm of bronchodilating compositions. His patents reflect a commitment to improving treatment options for individuals with bronchoconstrictive disorders. His contributions continue to impact the medical field positively.